US 10233438
Engineered primate L-methioninase for therapeutic purposes
granted A61KA61K35/12A61K38/51
Quick answer
US patent 10233438 (Engineered primate L-methioninase for therapeutic purposes) held by The Board of Regents of the University of Texas System expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/12, A61K38/51, A61K45/06, A61P